Strictly Follow Policy Requirements, Implement Quality Work, and Strengthen Drug Safety -- Our Company Participates in the Promotion Meeting for Implementing the Supervision and Management Regulations on the Main Responsibility for Quality and Safety

To further promote the laws, regulations, and policies on drug production supervision, urge enterprises to fulfill the main responsibility for quality and safety, and firmly safeguard the bottom line of drug quality and safety, On March 21, the "Promotion Meeting on the Supervision and Management Regulations for Enterprises to Fulfill the Main Responsibility for Quality and Safety of Drugs, Medical Devices, and Cosmetics," hosted by the Comprehensive Department, Drug Supervision Department, Medical Device Supervision Department, and Cosmetics Supervision Department of the National Medical Products Administration, was held as scheduled through offline training plus online live broadcast. Our company leadership attaches great importance to this training meeting. General Manager Yao Xiaodong, along with relevant personnel, attended the entire meeting through online learning and studied diligently!

(Photo of the meeting site)

The meeting officially kicked off with a speech by Wu Shaozhen, Chairman of China Health Media Group! At the meeting, Yuan Lin, Director of the Drug Supervision Department of the National Medical Products Administration, gave a detailed interpretation of the recently issued and implemented "Supervision and Management Regulations for Drug Marketing Authorization Holders to Fulfill the Main Responsibility for Drug Quality and Safety". Wang Zhexiong, Director of the Medical Device Supervision Department, Li Jinju, Director of the Cosmetics Supervision Department of the National Medical Products Administration, and Shao Rong, Executive Dean of the Drug Regulatory Science Research Institute of China Pharmaceutical University, respectively promoted the laws and regulations related to drug production, including the "Supervision and Management Regulations for Enterprises to Fulfill the Main Responsibility for Medical Device Quality and Safety," "Supervision and Management Regulations for Enterprises to Fulfill the Main Responsibility for Cosmetics Quality and Safety," and "Supervision and Management Regulations for Drug Marketing Authorization Holders to Fulfill the Main Responsibility for Drug Quality and Safety." The meeting required enterprises to further strengthen awareness of laws and regulations, quality awareness, and main responsibility awareness, firmly establish bottom-line thinking and risk thinking, and strictly implement the requirements of "Two Lists, Dual Reports, One Commitment," and lawfully fulfill the main responsibility for drug quality and safety and its supervision and management regulations.

Through this training, the participants have gained a comprehensive understanding of the new regulations, which has greatly promoted how everyone will fulfill the main responsibility for drug quality and safety in their future work, and is conducive to the company better implementing GMP to better ensure the quality and safety of drugs!

Our company has always attached great importance to drug quality and safety work. The company's senior management has always regarded drug quality and safety as a top priority. Through long-term exploration, the company has established a complete set of scientific, standardized, and rigorous quality control systems, created a full-chain quality traceability system from material sources to the end market, and firmly established the drug quality and safety guarantee line. We deeply understand that enterprises are the first responsible party for drug quality and safety. Next, we will further raise awareness, implement the main responsibility regulations for quality and safety, continuously improve and optimize the quality management system, strengthen control over production and operation processes and product quality control, and ensure continuous legal and compliant production and operation! We are determined to fulfill the mission of "making quality drugs for people worldwide"!